Addressing the Lack of Diversity in Clinical Trials: Four Lessons for Healthcare Leaders

The lack of diversity in clinical trials is a longstanding issue in healthcare. The underrepresentation of diverse ethnic backgrounds, particularly among Hispanic and Black populations, hinders a comprehensive understanding of medical treatments' efficacy and safety. To address this, healthcare leaders must build strategic partnerships with community organizations, address participation barriers, and empower healthcare providers to promote diversity in research. These initiatives can help improve the representation of underrepresented populations in clinical trials, ensuring better healthcare outcomes for all. Abbott's Diversity in Research Office serves as a model for success in this regard.